5 Results for "

AZD5991

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "AZD5991" in MCE Product Catalog:

22
22 Cited Publications
Cat. No.: HY-101533
CAS No.: 2143061-81-6
Purity:  99.79%
Target:  

Bcl-2 Family

Research Areas:  

Cancer

AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay .
loading...
    loading...
Cat. No.: HY-101533A
CAS No.: 2143010-83-5
Target:  

Bcl-2 Family

Research Areas:  

Cancer

AZD-5991 Racemate is the racemate of AZD-5991. AZD-5991 Racemate is a Mcl-1 inhibitor with an IC50 of <3 nM in FRET assay.
loading...
    loading...
Cat. No.: HY-101533B
CAS No.: 2143061-82-7
Purity:  99.83%
Target:  

Bcl-2 Family

Research Areas:  

Cancer

AZD-5991 S-enantiomer is the less active enantiomer of AZD-5991. AZD-5991 S-enantiomer is a Mcl-1 inhibitor with an IC50 of 6.3 μM in FRET assay and a Kd of 0.98 μM in surface plasmon resonance (SPR) assay.
loading...
    loading...
Cat. No.: HY-101533R
CAS No.: 2143061-81-6
Research Areas:  

Cancer

AZD-5991 (Standard) is the analytical standard of AZD-5991 (HY-101533). This product is intended for research and analytical applications. AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay .
loading...
    loading...
Cat. No.: HY-180941
Target:  

Bcl-2 Family Caspase

Research Areas:  

Cancer

Bfl-1-IN-7 is an orally active and selective Bfl-1 inhibitor with an IC50 value of 0.015 μM. Bfl-1-IN-7 activates caspase 3/7, and when combined with the Mcl-1 inhibitor AZD5991 (HY-101533), it reduces the viability of lymphoma cells. Bfl-1-IN-7 can be used in lymphoma-related studies .
loading...
    loading...